Aflac (NYSE:AFL) Director Charles Lake II Sells 15,590 Shares

Aflac Incorporated (NYSE:AFL) Director Charles Lake II sold 15,590 shares of Aflac stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $109.93, for a total value of $1,713,808.70. Following the sale, the director directly owned 62,237 shares of the company’s stock, valued at approximately $6,841,713.41. The trade was a 20.03% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Aflac Stock Performance

Shares of NYSE AFL opened at $108.73 on Friday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.11 and a quick ratio of 0.11. Aflac Incorporated has a one year low of $96.95 and a one year high of $119.32. The business’s 50-day moving average price is $111.63 and its two-hundred day moving average price is $110.30. The company has a market capitalization of $56.14 billion, a P/E ratio of 15.80, a price-to-earnings-growth ratio of 3.59 and a beta of 0.66.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, February 4th. The financial services provider reported $1.57 earnings per share for the quarter, missing the consensus estimate of $1.69 by ($0.12). Aflac had a return on equity of 14.35% and a net margin of 21.24%.The firm had revenue of $4.28 billion during the quarter, compared to analyst estimates of $4.45 billion. During the same period in the previous year, the company earned $1.57 earnings per share. The business’s revenue for the quarter was down 9.6% on a year-over-year basis. Analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current fiscal year.

Analyst Ratings Changes

AFL has been the topic of several recent research reports. Weiss Ratings reaffirmed a “buy (b+)” rating on shares of Aflac in a research report on Monday, December 22nd. Wells Fargo & Company boosted their target price on shares of Aflac from $109.00 to $118.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 25th. Raymond James Financial restated an “outperform” rating and set a $119.00 price target (up from $110.00) on shares of Aflac in a research note on Tuesday, December 30th. Wall Street Zen downgraded shares of Aflac from a “hold” rating to a “sell” rating in a report on Saturday, February 28th. Finally, Mizuho set a $107.00 price objective on shares of Aflac in a report on Monday, February 9th. Three investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $111.73.

Institutional Investors Weigh In On Aflac

A number of large investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its holdings in Aflac by 13.4% during the fourth quarter. Vanguard Group Inc. now owns 57,142,072 shares of the financial services provider’s stock valued at $6,301,056,000 after purchasing an additional 6,759,169 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Aflac by 1.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 4,483,205 shares of the financial services provider’s stock worth $494,385,000 after buying an additional 69,025 shares during the last quarter. Invesco Ltd. boosted its holdings in shares of Aflac by 16.7% during the 2nd quarter. Invesco Ltd. now owns 4,167,886 shares of the financial services provider’s stock worth $439,545,000 after buying an additional 594,971 shares during the period. Norges Bank acquired a new position in Aflac in the 2nd quarter valued at $432,201,000. Finally, Legal & General Group Plc grew its stake in Aflac by 0.3% in the 3rd quarter. Legal & General Group Plc now owns 3,926,777 shares of the financial services provider’s stock valued at $438,621,000 after buying an additional 13,666 shares during the last quarter. Institutional investors own 67.44% of the company’s stock.

Key Stories Impacting Aflac

Here are the key news stories impacting Aflac this week:

• Positive Sentiment: New distribution deal: Aflac announced a partnership with Empower Brokerage to distribute supplemental-insurance products, which should broaden channels for sales and support premium growth over time. Read More.
• Neutral Sentiment: Earnings/fundamentals context: Aflac’s Feb. 4 quarter showed an EPS miss and revenue decline year-over-year; consensus remains a “Hold” with an average target around $111. That keeps analysts cautious and caps upside absent clearer improvement in top-line trends.
• Neutral Sentiment: Human-interest coverage: Aflac ran a feature on a policyholder’s cancer journey (brand/PR positive but unlikely to move the stock materially). Read More.
• Negative Sentiment: Director insider sale: Director Charles D. Lake II sold 15,590 shares (avg. ~$109.93) on Mar. 11. Insider sales can be read negatively by the market even if motivated by personal reasons; SEC Form 4 filed. Read More.
• Negative Sentiment: Major shareholder trimming: Post Holdings (Japan) has executed several small block sales (multiple ~17k–19k-share trades across Mar. 5–11). Sales are small relative to its >10% stake but add supply and suggest portfolio rebalancing rather than confidence-boosting buying. Read More.
• Negative Sentiment: Cybersecurity incident disclosed: Media reports say Aflac confirmed a cybersecurity breach; details remain limited. Potential data, remediation costs, regulatory follow-ups or client impact make this the most direct near‑term operational risk in the headlines. Read More.

Aflac Company Profile

Aflac Incorporated (American Family Life Assurance Company of Columbus) is a provider of supplemental insurance products designed to help policyholders manage out-of-pocket health care and living expenses. The company underwrites a range of individual and group policies that typically pay cash benefits directly to insureds when covered events occur, enabling greater financial flexibility for medical treatment, hospital stays, critical illness, and related costs. Aflac’s product mix includes supplemental health insurance, life insurance and other specialty coverages intended to complement primary medical plans.

Founded in the mid-20th century and headquartered in Columbus, Georgia, Aflac distributes its products through a combination of employer-sponsored programs, independent brokers and agents, and direct marketing.